Marketing Authorisation Holder

Mylan Laboratories Limited

INDIA

GMP Certified

Prestige Tech Park,Platina-3, PRESTIGE TECH PARK, 7th to 12th, Kadubeesanahalli, Bengaluru, Bellandur Amanikere, Karnataka 560103, India

Bengaluru, India

Maps

411

Total Medicines

293

Active

Dosage Forms

Countries

Tanzania (87) Zimbabwe (84) Botswana (56) Kenya (44) Uganda (43) Zambia (41) Ghana (30) Rwanda (26)

Location

Prestige Tech Park,Platina-3, PRESTIGE TECH PARK, 7th to 12th, Kadubeesanahalli, Bengaluru, Bellandur Amanikere, Karnataka 560103, India

Open in OpenStreetMap approx.

Registration Status

Registered 293

PRESCRIPTION PREPARATIONS 9TH SCHEDULE, (P.P.) 67

Valid 17

PRESCRIPTION PREPARATIONS 10TH SCHEDULE, (P.P.10) 15

3 months to expiry 13

Unknown 3

PHARMACIST INITIATED MEDICINES, (P.I.M.) 2

Retained 1

Dosage Forms

Tablets 53 TABLET, COATED; ORAL 38 Film Coated Tablet 24 ORAL SOLID ORDINARY FILM-COATED TABLETS 22 TABLET; ORAL 21 TABLET 20 ORAL SOLID ORDINARY TABLETS 15 TABLETS 12

Therapeutic Classes

GENERIC/BIOSIMILARS 33

NEW/INNOVATOR 7

Local Agents / Applicants

MYLAN LABORATORIES LIMITED 149

Mylan Laboratories Limited 124

MYLAN LABORATORIES LIMITED... 55

MYLAN LABORATORIES LIMITED [OTL] 15

Worldwide Healthcare... 13

Worldwide Healthcare... 9

Distributing Wholesalers

Licensed wholesalers / distributors that carry this MAH's brands.

Harleys Pharmaceutical

Westlands, Nairobi

8 SKUs

Eastleigh Pharmaceutical

Eastleigh, Nairobi

7 SKUs

Generics Africa

Nairobi

2 SKUs

Browse all wholesalers

Registered Medicines

Showing 20 of 411 · Page 1 of 21

Search all

Product	Form / Strength	Country	Reg. Number	Status
ABACAVIR (AS SULFATE)/LAMIVUDINE 120MG/60MG DISPERSIBLE TABLETS Abacavir Sulfate USP 120mg/Lamivudine USP 60mg	Biconvex tablets 120mg/60mg	Rwanda	Rwanda FDA-HMP-MA-0134	Registered
ABACAVIR SULFATE & LAMIVUDINE -	TABLET	Botswana	BOT1903561	Registered/Compliant
ABACAVIR SULFATE + DOLUTEGRAVIR SODIUM + LAMIVUDINE -	ORAL SOLID ORDINARY FILM-COATED TABLETS 60 MG + 5 MG + 30 MG	Uganda	NDA/MAL/HDP/11524	Registered
ABACAVIR SULFATE + LAMIVUDINE -	ORAL SOLID ORDINARY SOLUBLE TABLETS 120 MG + 60 MG	Uganda	NDA/MAL/HDP/9266	Registered
ABACAVIR SULFATE + LAMIVUDINE -	ORAL SOLID ORDINARY TABLETS 600 MG + 300 MG	Uganda	NDA/MAL/HDP/4280	Registered
ABACAVIR SULFATE /LAMIVUDINE TABLETS 600 MG/300 MG ABACAVIR SULFATE AND LAMIVUDINE	ABACAVIR SULFATE 600MG / LAMIVUDINE 300MG	Kenya	H2017/CTD3966/102	Registered
ABACAVIR SULFATE/ LAMIVUDINE TABLETS 120MG/60MG ABACAVIR SULFATE USP LAMIVUDINE USP	ABACAVIR SULFATE 120MG USP LAMIVUDINE USP 60MG	Kenya	H2021/CTD5356/1606ER	Registered
ABACAVIR SULFATE/LAMIVUDINE 120MG/60MG DISPERSIBLE TABLETS (Each dispersible tablet contains Abacavir Sulfate/Lamivudine 120mg/60mg) Abacavir Sulfate/Lamivudine	Abacavir Sulfate/Lamivudine 120mg/60mg	Ghana	FDA/GD.255-100200	Valid
ABACAVIR SULFATE/LAMIVUDINE TABLETS USP 600 MG/300 MG Abacavir Sulfate 600 mg/Lamivudine 300 mg	Film Coated Tablets 600 mg/ 300 mg	Rwanda	Rwanda FDA-HMP-MA-0122	Registered
ABACAVIR SULFATE; LAMIVUDINE ABACAVIR SULFATE; LAMIVUDINE	TABLET; ORAL 120; 60MG	Zimbabwe	2018/7.13/5589	PRESCRIPTION PREPARATIONS 9TH SCHEDULE, (P.P.)
ABACAVIR SULPHATE; LAMIVUDINE ABACAVIR SULPHATE; LAMIVUDINE	TABLET; ORAL 600; 300MG	Zimbabwe	2015/7.13/4973	PRESCRIPTION PREPARATIONS 9TH SCHEDULE, (P.P.)
ABACAVIR TABLETS -	TABLET	Botswana	BOT0801281	Registered/Compliant
ABACAVIR/ LAMIVUDINE -	DISPERSIBLE TABLETS	Botswana	BOT2404242	Registered/Compliant
ABACAVIR/ LAMIVUDINE -	DISPERSIBLE TABLETS	Botswana	BOT2404242A	Registered/Compliant
ABACAVIR/ LAMIVUDINE -	DISPERSIBLE TABLETS	Botswana	BOT2404242B	Registered/Compliant
ABACAVIR/ LAMIVUDINE 1 -	DISPERSIBLE TABLETS	Botswana	BOT2404242C	Registered/Compliant
ABACAVIR/LAMIVUDINE 600MG/300MG TABLETS (Each film-coated tablet contains Abacavir Sulfate/Lamivudine 600mg/300mg) Abacavir Sulfate/Lamivudine	Abacavir Sulfate/Lamivudine 600mg/300mg	Ghana	FDA/GD.255-100204	Valid
ABAMAT TABLETS ABACAVIR SULPHATE	TABLET, COATED; ORAL 300MG	Zimbabwe	2008/7.13/4535	PRESCRIPTION PREPARATIONS 9TH SCHEDULE, (P.P.)
ACRIPTEGA Lamivudine, Tenofovir disoproxil fumarate and Dolutegravir Tablets 300 mg/300 mg/50 mg	Tablets 300 mg/300 mg/50 mg	Rwanda	Rwanda FDA-HMP-MA-0410	Registered
ACRIPTEGA DOLUTEGRAVIR; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE	TABLET, COATED; ORAL 50; 300; 300MG	Zimbabwe	2018/7.13/5737	PRESCRIPTION PREPARATIONS 9TH SCHEDULE, (P.P.)

1 2 3 ... 21 Next

411 products